Press coverage about Dolby Laboratories (NYSE:DLB) has trended somewhat positive on Sunday, according to Accern. Accern rates the sentiment of media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Dolby Laboratories earned a media sentiment score of 0.10 on Accern’s scale. Accern also gave news articles about the electronics maker an impact score of 44.9455457930627 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.
These are some of the news articles that may have effected Accern Sentiment Analysis’s scoring:
- Dolby Laboratories Inc (DLB) President and CEO Kevin J Yeaman Sold $6.2 million of Shares (finance.yahoo.com)
- Dolby Laboratories, Inc. (DLB) CEO Sells $3,066,000.00 in Stock (americanbankingnews.com)
- Mark Andrew Sherman Sells 81,554 Shares of Dolby Laboratories, Inc. (DLB) Stock (americanbankingnews.com)
- Dolby Laboratories, Inc. (DLB) Insider Kevin J. Yeaman Sells 100,000 Shares (americanbankingnews.com)
- Brokerages Expect Dolby Laboratories, Inc. (DLB) Will Post Quarterly Sales of $299.35 Million (americanbankingnews.com)
DLB has been the subject of a number of recent analyst reports. Zacks Investment Research cut Dolby Laboratories from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 31st. B. Riley set a $66.00 price objective on Dolby Laboratories and gave the company a “buy” rating in a research report on Thursday, October 19th. Finally, JPMorgan Chase & Co. raised their price objective on Dolby Laboratories from $63.00 to $70.00 and gave the company a “neutral” rating in a research report on Thursday, January 25th. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $62.00.
Dolby Laboratories (DLB) traded up $0.21 on Friday, hitting $60.19. The stock had a trading volume of 579,102 shares, compared to its average volume of 488,621. The firm has a market capitalization of $6,156.71, a PE ratio of 25.50, a price-to-earnings-growth ratio of 5.07 and a beta of 0.78. Dolby Laboratories has a 52 week low of $47.41 and a 52 week high of $74.29.
Dolby Laboratories (NYSE:DLB) last released its quarterly earnings results on Wednesday, January 24th. The electronics maker reported $0.79 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.44 by $0.35. The business had revenue of $287.80 million during the quarter, compared to analysts’ expectations of $265.75 million. Dolby Laboratories had a return on equity of 12.02% and a net margin of 6.06%. The firm’s revenue for the quarter was up 8.1% compared to the same quarter last year. During the same period last year, the firm posted $0.66 EPS. equities analysts forecast that Dolby Laboratories will post 0.99 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Wednesday, February 14th. Investors of record on Monday, February 5th will be issued a dividend of $0.16 per share. The ex-dividend date is Friday, February 2nd. This represents a $0.64 annualized dividend and a yield of 1.06%. Dolby Laboratories’s payout ratio is currently 101.59%.
In related news, Director Peter C. Gotcher sold 5,233 shares of Dolby Laboratories stock in a transaction that occurred on Tuesday, February 6th. The stock was sold at an average price of $62.12, for a total transaction of $325,073.96. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Kevin J. Yeaman sold 11,130 shares of Dolby Laboratories stock in a transaction that occurred on Monday, December 18th. The stock was sold at an average price of $62.47, for a total value of $695,291.10. The disclosure for this sale can be found here. Over the last three months, insiders have sold 761,989 shares of company stock valued at $47,521,183. 43.80% of the stock is currently owned by insiders.
TRADEMARK VIOLATION NOTICE: “Dolby Laboratories (DLB) Given Daily News Sentiment Rating of 0.10” was published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this piece on another domain, it was copied illegally and republished in violation of US and international trademark and copyright legislation. The legal version of this piece can be read at https://ledgergazette.com/2018/02/12/somewhat-favorable-news-coverage-somewhat-unlikely-to-impact-dolby-laboratories-dlb-stock-price.html.
About Dolby Laboratories
Dolby Laboratories, Inc designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. Its products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration.
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.